[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341725-105":59,"doc-detail-341725-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","vitronectin-levels-in-the-plasma-of-neuroblastoma-patients-and-culture-media-of-3d-models-a-prognostic-circulating-biomarker","Vitronectin Levels in the Plasma of Neuroblastoma Patients and Culture Media of 3D Models: A Prognostic Circulating Biomarker","","Vitronectin is a plasma and extracellular matrix glycoprotein linked to cell migration, with high levels in neuroblastoma biopsies associated with poor outcomes. This study evaluates vitronectin as a circulating prognostic biomarker by quantifying concentrations via ELISA in culture media from four neuroblastoma cell lines in monolayer and 3D models and in plasma from 114 patients. Vitronectin secretion is enhanced in 3D systems, including cross-linked vitronectin scaffolds, independent of cell number. Plasma levels range 52.4–870 µg/mL (median 218), and an ROC-derived cutoff of 361 µg/mL identifies patients over 18 months with worse prognosis (p=0.0018).",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/vitronectin-levels-in-the-plasma-of-neuroblastoma-patients-and-culture-media-of-3d-models-a-prognostic-circulating-biomarker/341725/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/vitronectin-levels-in-the-plasma-of-neuroblastoma-patients-and-culture-media-of-3d-models-a-prognostic-circulating-biomarker/341725.png","ImageObject",300,407,{"name":92,"@type":93},"Theodore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-16","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the study’s goal regarding vitronectin in neuroblastoma?","Question",{"text":112,"@type":113},"To assess vitronectin as a potential circulating biomarker for neuroblastoma prognosis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was vitronectin measured across cell models and patient plasma?",{"text":117,"@type":113},"Vitronectin concentration was quantified using ELISA in culture media of four neuroblastoma cell lines grown in monolayer and 3D models, and in plasma from 114 neuroblastoma patients.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the study find about vitronectin secretion in 3D models versus monolayer culture?",{"text":121,"@type":113},"Vitronectin release was higher in 3D models than in monolayer culture and remained elevated in 3D scaffolds with cross-linked vitronectin.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},341725,1791481299,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Article  \nVitronectin Levels in the Plasma of Neuroblastoma Patients and Culture Media of 3D Models: A Prognostic Circulating Biomarker?  \nAmparo López-Carrasco 1,2, Isaac Vieco-Martí 1,2, Sofía Granados-Aparici 1,2, Delia Acevedo-León 3, Nuria Estañ-Capell 3, Raquel Portugal 4, Jorge Huerta-Aragonés 5, Adela Cañete 6, Samuel Navarro 1,2,7 and Rosa Noguera 1,2,7, *  \nCitation: López-Carrasco, A.; Vieco-Martí, I.; Granados-Aparici, S.; Acevedo-León, D.; Estañ-Capell, N.; Portugal, R.; Huerta-Aragonés, J.; Cañete, A.; Navarro, S.; Noguera, R. Vitronectin Levels in the Plasma of Neuroblastoma Patients and Culture Media of 3D Models: A Prognostic Circulating Biomarker? Int. J. Mol. Sci. 2024, 25, 8733. [https://doi.org/](https://doi.org/)[ ](https://doi.org/)[10.3390/ijms25168733](10.3390/ijms25168733)  \nAcademic Editor: Mario Costa  \nReceived: 9 July 2024  \nRevised: 2 August 2024  \nAccepted: 9 August 2024  \nPublished: 10 August 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Incliva Biomedical Health Research Institute, 46010 Valencia, Spain;  \n[amparolopezcarrasco@gmail.com](amparolopezcarrasco@gmail.com) (A.L.-C.); [sograap@gmail.com](sograap@gmail.com) (S.G.-A.); [samuel.navarro@uv.es](samuel.navarro@uv.es) (S.N.)  \n2 CIBER of Cancer (CIBERONC), 28029 Madrid, Spain  \n3 University Hospital Doctor Peset, 46017 Valencia, Spain  \n4 General University Hospital of Burgos, 09006 Burgos, Spain; [rportugal@saludcastillayleon.es](rportugal@saludcastillayleon.es)  \n5 General University Hospital Gregorio Marañón, 28007 Madrid, Spain  \n6 Politechnic and University Hospital La Fe, 46026 Valencia, Spain  \n7 Pathology Department, Medical School, University of Valencia, 46010 Valencia, Spain  \n* Correspondence: rnoguera@uv.es  \nAbstract: Vitronectin is a glycoprotein present in plasma and the extracellular matrix that is implicated in cell migration. The high amount of vitronectin found in neuroblastoma biopsies has been associated with poor prognosis. Moreover, increased vitronectin levels have been described in the plasma of patients with different cancers. Our aim was to assess vitronectin as a potential circulating biomarker of neuroblastoma prognosis. Vitronectin concentration was quantified using ELISA in culture media of four neuroblastoma cell lines grown in a monolayer and in 3D models, and in the plasma of 114 neuroblastoma patients. Three of the neuroblastoma cell lines secreted vitronectin to culture media when culturedin a monolayer and 3D models. Vitronectin release was higher by neuroblastoma cells cultured in 3D models than in the monolayer and was still elevated when cells were grown in 3D scaffolds with cross-linked vitronectin. Vitronectin secretion occurred independently of cell numbers in cultures. Its concentration in the plasma of neuroblastoma patients ranged between 52.4 and 870 µg/mL (median, 218 µg/mL) . A ROC curve was used to establish a cutoff of 361 µg/mL, above which patients over 18 months old had worse prognosis (p = 0.0018) . Vitronectin could be considered a new plasma prognostic biomarker in neuroblastoma and warrants confirmation in collaborative studies. Drugs inhibiting vitronectin interactions with cells and/or the extracellular matrix could represent a significant improvement in survival for neuroblastoma patients.  \nKeywords: pediatric cancer; liquid biopsy; precision medicine; hydrogels; extracellular matrix  \n1. Introduction  \nVitronectin (VN), also known as serum spreading factor, is a multifunctional glycoprotein present in plasma and the extracellular matrix (ECM) [1] . It contains multiple cell receptor binding sites including integrins, urokinase-type plasminogen activator recept","cbCaifeX6Pdo2as1","https://ap.wps.com/l/cbCaifeX6Pdo2as1","pdf",1421837,14,"English","# Abstract\n# Introduction\n## Vitronectin function and relevance to cancer\n## Neuroblastoma background and prognosis","[{\"question\":\"What was the study’s goal regarding vitronectin in neuroblastoma?\",\"answer\":\"To assess vitronectin as a potential circulating biomarker for neuroblastoma prognosis.\"},{\"question\":\"How was vitronectin measured across cell models and patient plasma?\",\"answer\":\"Vitronectin concentration was quantified using ELISA in culture media of four neuroblastoma cell lines grown in monolayer and 3D models, and in plasma from 114 neuroblastoma patients.\"},{\"question\":\"What did the study find about vitronectin secretion in 3D models versus monolayer culture?\",\"answer\":\"Vitronectin release was higher in 3D models than in monolayer culture and remained elevated in 3D scaffolds with cross-linked vitronectin.\"}]","Vitronectin Levels in the Plasma of Neuroblastoma Patients and Culture Media of 3D Models: A Prognostic Circulating Biomarker | PDF",1790043383,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bd5047d50a02439368ba92142f49469d.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ce8f5970895edea7f11a238344bf0617.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a8eec23279cbb30cbd1b9c843cd9c165.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/036b0ec12e91a43f1dc8cbe739825f03.webp",980,1385]